Latest
Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.
Australia is the world’s largest producer of lithium and has the second-largest lithium reserves accounting for 5.7 million metric tons....
vc_rowvc_column width=”1/6″/vc_columnvc_column width=”2/3″vc_column_text Entrepreneurship Risky For Youth In India:...
BUDDING ENTREPRENEURS AND STUDENTS WHO POSSESS AN INNOVATIVE BUSINESS PLAN WILL APPROACH ANGEL INVESTORS OR VENTURE CAPITALISTS FOR...